Bill Text: IL HB3682 | 2021-2022 | 102nd General Assembly | Introduced
Bill Title: Creates the COVID-19 Workplace Vaccination Program Limitation Act. Provides that it is unlawful for an employer in the State of Illinois to create, implement, or otherwise enforce a workplace vaccination program that requires any employee to demonstrate to the employer that he or she has received a vaccine that was approved under emergency use authorization by the United States Food and Drug Administration. Provides for repeal of the Act on January 1, 2023. Effective immediately.
Spectrum: Partisan Bill (Republican 18-0)
Status: (Introduced - Dead) 2022-02-10 - Added Co-Sponsor Rep. Mark Luft [HB3682 Detail]
Download: Illinois-2021-HB3682-Introduced.html
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
1 | AN ACT concerning employment.
| ||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||
4 | Section 1. Short title. This Act may be cited as the | ||||||||||||||||||||||||
5 | COVID-19 Workplace Vaccination Program Limitation Act.
| ||||||||||||||||||||||||
6 | Section 5. Purpose. It is the purpose of this Act to allow | ||||||||||||||||||||||||
7 | individuals to have the autonomy to make the decision of | ||||||||||||||||||||||||
8 | whether or not to receive a vaccination that was approved by | ||||||||||||||||||||||||
9 | the United States Food and Drug Administration to be used | ||||||||||||||||||||||||
10 | under emergency use authorization for treatment of COVID-19. | ||||||||||||||||||||||||
11 | The fact that the vaccines made available amid the global | ||||||||||||||||||||||||
12 | pandemic have been granted emergency use authorization means | ||||||||||||||||||||||||
13 | that both regulatory bodies and industry experts have not been | ||||||||||||||||||||||||
14 | allotted sufficient time to study either the short-term and | ||||||||||||||||||||||||
15 | long-term effects that may arise from the administration of | ||||||||||||||||||||||||
16 | vaccinations authorized for emergency use. Therefore, the | ||||||||||||||||||||||||
17 | State is compelled to prohibit employers from requiring that | ||||||||||||||||||||||||
18 | employees receive a vaccine that has been approved under | ||||||||||||||||||||||||
19 | emergency use authorization as a condition of employment.
| ||||||||||||||||||||||||
20 | Section 10. Prohibition. It is unlawful for an employer in | ||||||||||||||||||||||||
21 | the State of Illinois to create, implement, or otherwise | ||||||||||||||||||||||||
22 | enforce a workplace vaccination program that requires an |
| |||||||
| |||||||
1 | employee to demonstrate to the employer that he or she has | ||||||
2 | received a vaccine that was approved under emergency use | ||||||
3 | authorization by the United States Food and Drug | ||||||
4 | Administration, under the Administration's power outlined in | ||||||
5 | Section 564 of the Federal Food, Drug, and Cosmetic Act, for | ||||||
6 | protection against COVID-19.
| ||||||
7 | Section 95. Repeal. This Act is repealed on January 1, | ||||||
8 | 2023.
| ||||||
9 | Section 99. Effective date. This Act takes effect upon | ||||||
10 | becoming law.
|